Amicus Therapeutics Story Overview

FOLD -- USA Stock  

USD 15.76  0.16  1.03%

Macroaxis does not monitor all media channels or aggregates social signals for Amicus Therapeutics. But even though we do not provide professional-grade financial sentiment analysis on Amicus Therapeutics, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Amicus Therapeutics. Additionally see Amicus Therapeutics Hype Analysis, Amicus Therapeutics Correlation and Amicus Therapeutics Performance.
Acquisition by Hung Do of 29803 shares of Amicus Therapeutics subject to Rule 16b-3
Filed transaction by Amicus Therapeutics Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Amicus Therapeutics Inc insider trading alert for grant of common stock by Hung Do, Chief Science Officer, on January 3, 2018. This event was filed by Amicus Therapeutics Inc with SEC on 2018-01-05. Statement of changes in beneficial ownership - SEC Form 4. Hung Do is currently serves as senior vice president - discovery biology of Amicus Therapeutics Inc

Story Momentum

This media report from MacroaxisInsider distributed on January 3, 2018 was a factor to the next trading day price decrease.The overall trading delta against the next closing price was 1.47% . The overall trading delta when the story was published against the current closing price is 0.57% .

Similar stores for Amicus Therapeutics

2 days ago at www.macroaxis.com 
Conversion by Topper James N of 5016 shares of Amicus Therapeutics
Macroaxis News
Filed transaction by Amicus Therapeutics Inc director. Derivative codes conversion of derivative security
six days ago at http://hillaryhq.com 
As Centene Del Valuation Rose, Prescott Group Capital Management Increased Holding by 477000 Amicus ...
news
Hillary HQ Mind-Blowing Stocks- Amicus Therapeutics, Inc. , Alaska Air Group, Inc. , VIVUS, Inc ... The Stock Street What Will Happen to Amicus Therapeutics, Inc. Next The Stock Just Increased A Lot The Casual SmartAmicus Therapeutics -10 percent on missed CMA in Europe Seeking AlphaFull coverage
Securities Analyst Recommendations Amicus Therapeutics, Inc. , Consolidated Communications Holdings, Inc ...news
Analyst JournalFull coverage
over two weeks ago at http://nysewired.com 
Stock Performance Recap Amicus Therapeutics, Inc.
wired  News
NYSE WIRED Full coverage
over two weeks ago at http://www.thewellesleysnews.com 
Equity Research Analysts Stock Ratings Pure Storage, Inc. , Amicus Therapeutics, Inc.
news
Analyst JournalFull coverage
over three weeks ago at http://www.nysetradingnews.com 
Make a hit with these Stocks Merck Co., Inc., , Amicus Therapeutics, Inc.,
news
Nyse Trading News Full coverage
over three weeks ago at http://www.stocksnewspoint.com 
200 days simple moving average Indicator Evaluation DowDuPont Inc. , Amicus ...
news
Stocks News Point WHY RECEIVING PLENTY OF ATTENTION AMC Entertainment Holdings, Inc., , Amicus Therapeutics ... Nyse Trading News Full coverage
over a month ago at http://www.stocknewsgazette.com 
Amicus Therapeutics exotic insider transaction detected
news
Filed transaction by Amicus Therapeutics Inc officer. Unconventional Insider trading
over a month ago at http://www.nysetradingnews.com 
Notable Worth Watching Stocks Tetraphase Pharmaceuticals, Inc., , Amicus Therapeutics, Inc ...
news
Nyse Trading News Full coverage
over a month ago at http://macondaily.com 
Amicus Therapeutics, Inc. Expected to Post Earnings of -0.33 Per Share
news
Macon DailyAmicus Therapeutics Downgraded to Buy at BidaskClub Week HeraldRockefeller Capital Management LP Acquires Shares of 19169 Amicus Therapeutics, Inc. registrarjournal.comFull coverage
over a month ago at http://thewellesleysnews.com 
How Have Amicus Therapeutics, Inc. EPS Outlook Changed
news
Analyst JournalFull coverage
over two months ago at http://stockspen.com 
Hot Mover of the Day Amicus Therapeutics Inc
news
Stocks PenFull coverage
over three months ago at http://normanweekly.com 
Bryn Mawr Trust Company Position In Cirrus Logic Was Increased As Amicus Therapeutics Stock ...
news
Norman WeeklyEvercore Wealth Management Lifted Medtronic Plc Position by 1.22 Million as Shares Rose Amicus ... HuronReportVenbio Select Advisor Has Upped Its Amicus Therapeutics Position Lakewood Capital Management LP ... Bibeypost.comFull coverage

EBITDA

EBITDA Comparative Analysis
  EBITDA 
      Amicus Therapeutics Comparables 
Amicus Therapeutics is currently under evaluation in ebitda category among related companies. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Peers

Amicus Therapeutics Related Equities
CO  4.49 %   
0%
100.0%
DRNA  0.96 %   
0%
21.0%
DVAX  0.64 %   
0%
14.0%
DNLI  0.36 %   
7.0%
0%
DOVA  0.54 %   
12.0%
0%
ECYT  0.77 %   
17.0%
0%
EDGE  0.97 %   
21.0%
0%
NK  2.27 %   
50.0%
0%
EARS  2.94 %   
65.0%
0%
DMPI  4.04 %   
89.0%
0%
Additionally see Amicus Therapeutics Hype Analysis, Amicus Therapeutics Correlation and Amicus Therapeutics Performance. Please also try Financial Widgets module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.